Alexza Pharma (ALXA) – Major News
-
Grupo Ferrer to Acquire Alexza Pharma (ALXA) for 90c/Share
-
Alexza Pharma (ALXA) Reports Q1 Loss of $0.16
-
Grupo Ferrer to Acquire Alexza Pharma (ALXA) for 90c/Share in Cash
-
Alexza Pharma (ALXA) Reports Q4 Loss of $0.15/Share; Warns it May Shut Down
-
Alexza Pharma (ALXA) Tops Q3 EPS by 7c
-
Alexza Pharma (ALXA) Will Explore Strategic Options
-
Alexza Pharma (ALXA) Misses Q2 EPS by 3c
-
Alexza Pharma (ALXA) Tops Q1 EPS by 49c
-
Alexza Pharma (ALXA) Tops Q4 EPS by 33c
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
-
Alexza Pharmaceuticals, Inc. (ALXA) Poster Larger than Expected Q3 Loss
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Mixed Q2 Results
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Q1 Loss of $1.31/Share
-
Aeva Pharma (ALXA), Teva (TEVA) Enter Exclusive License for ADASUVE
-
Alexza Pharmaceuticals (ALXA) Reports Q4 Loss of $0.65
-
FDA Approves Alexza's (ALXA) Adusave
-
Alexza Pharma (ALXA) Receives Positive Opinion on ADASUVE from CHMP
-
EMA issues positive recommendation for Alexza's (ALXA) Adasuve
-
Alexza Pharmaceuticals, Inc. (ALXA) Reports Q3 Loss of $0.52
-
Alexza Pharmaceuticals, Inc. (ALXA) Tops Q1 EPS by 4c
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Q4 Loss of 13c/Share
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Q3 GAAP Loss of 19c/Share
-
Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 EPS Loss of $0.13
-
Alexza Pharmaceuticals Inc. (ALXA) Posts Q1 EPS Loss of $0.14, Tops Consensus by 7c
-
Alexza Pharma (ALXA) Posts Q4 GAAP EPS of $0.42
-
Alexza Pharmaceuticals (ALXA) Reports Small Q3 Loss; Comments on Expected Q4 Revenues
-
Alexza (ALXA) Shares Cut In Half After FDA Calls AZ-004 Not Approvable
-
Alexza (ALXA) Receives CRL From FDA On AZ-004 Stating It is Not Ready for Approval, Shares Plunge
-
Alexza Pharma (ALXA) Posts Q4 Loss of $0.39, Wider than Expected
-
Alexza Pharmaceuticals (ALXA) Announces 10/11/10 PDUFA for AZ-004
-
Alexza Pharmaceuticals (ALXA) Announces Collaboration With Biovail (BVF), $40M Upfront
-
Alexza Pharmaceuticals (ALXA) Reports Large Q3 Loss
-
Alexza Pharmaceuticals (ALXA) Tops Q3 EPS by 3c
-
Alexza Pharmaceuticals (ALXA) Tops Q2 EPS by 4c
-
Alexza Pharma (ALXA) Misses Q1 EPS by 7c
-
Alexza Pharmaceuticals (ALXA) Reports Q4 Loss of $0.42, Misses By 6c
Back to ALXA Stock Lookup